AGP Executive Report

UK Healthcare Policy: Devon Partnership NHS Trust became England’s first NHS trust to formalize inpatient medical cannabis procedures, setting rules for verifying legally prescribed products, storage, and administration during admissions. US Federal Cannabis Push: Senate Democrats reintroduced the Cannabis Administration and Opportunity Act to remove cannabis from the Controlled Substances Act, aiming to expand research access and reduce federal enforcement fallout. State/Local Cannabis Rollout: Hanover County, Virginia, moved to draft local ordinances for the state’s upcoming retail cannabis market, with local input tied to licensing decisions ahead of 2027. Medical Cannabis Access & Pain: Medigrowth partnered with Chronic Pain Australia for National Pain Week, citing survey data showing growing use and interest in medicinal cannabis for chronic pain management. CBD Consumer Market: A new report projects rapid growth for hemp-infused seltzers, driven by demand for alcohol-free wellness drinks featuring CBD and hemp-derived ingredients. Hemp Product Regulation: A US bill would regulate hemp products instead of banning them, reflecting ongoing policy fights over THC-containing hemp goods. Research/Clinical Angle: Coverage highlights mixed results in supplement science, including how omega-3 trials often fail to deliver cognition benefits—useful context for how CBD claims may be scrutinized. Agriculture & Weed Control (Indirect): UK farming coverage stresses stronger pre-emergence herbicide programs and warns about herbicide carryover into cover crops, underscoring the broader weed-management backdrop for hemp and CBD supply chains.

THC Beverages Under Fire: Doctors say THC drinks sold beside soda and iced tea are landing kids in the ER, with labeling and ID checks often missing as a Farm Bill loophole nears its November close. Federal Legalization Push: Senate Democrats reintroduced the Cannabis Administration and Opportunity Act, aiming to decriminalize marijuana, expunge certain federal offenses, and set a federal regulatory framework. Hemp-THC Deadline Pressure: Coverage highlights the looming end of hemp-THC shelf access and the scramble by states and businesses to adapt. Medical Cannabis in the Real World: A small Colorado workers’ comp pilot explores whether medical marijuana can help injured workers reduce opioid reliance—while broader access remains limited. Research & Safety Watch: A new op-ed warns high-potency cannabis use starting in early teens is linked to worse mental health outcomes, including psychosis risk. Industry/Business: Alpine IQ expands its partnership with Digital Awesome to boost loyalty and retention tools for cannabis retailers via branded mobile apps. Global Hemp Growth: Botswana is pushing industrial hemp trials as a jobs-and-business alternative to diamond dependence.

Hemp & Marijuana Policy: A North Carolina podcast episode digs into why THC products thrive in the “wild west” of hemp while marijuana stays illegal, unpacking the politics and legal system behind the controversy. Legal & Courts: A California jury found former UC Davis student Carlos Reales Dominguez guilty of involuntary manslaughter in a 2023 stabbing spree, while rejecting murder and attempted murder charges. Medical/Research: Radiopharm Theranostics raised about $16M after trial updates for its RAD-101 brain metastases imaging agent, reporting strong scan performance versus MRI and follow-up results. Public Safety & Enforcement: California’s CHP announced $41M in impaired-driving grants funded by cannabis taxes, supporting enforcement, education, and forensic toxicology testing. Industry/Business: A Las Vegas guide highlights what to look for when choosing a dispensary, focusing on sourcing, product quality, and selection.

Hemp-THC Regulation Deadline: Convenience retailers are being urged to push for regulation as hemp-derived THC beverages face a looming Nov. 12 federal deadline that could upend mainstream shelves. Medical Cannabis Policy: Vermont raised the daily cannabis purchase limit from 1 ounce to 2 under a new law aimed at steering buyers toward licensed dispensaries instead of the illicit market. Federal Legal Pressure: A Utah judge refused to block an NLRB case accusing a medical marijuana dispensary of firing union supporters, keeping the labor fight alive. Ballot Access: Massachusetts cleared a legal challenge tied to signature integrity for a retail marijuana repeal question, setting up a November vote. Industry Compliance Costs: Oregon regulators are seeking steep fee hikes for its psilocybin program, with critics warning the costs could force more service center closures. Public Safety & Enforcement: Vancouver’s police guild is pushing back on city attorney directives telling officers not to arrest or cite for a range of offenses, including marijuana possession by those under 21, citing budget-driven gaps in enforcement. Research & Patents: A new look at cannabis patent activity suggests a “gold rush” effect as rescheduling expectations and state legalization spur filings.

THC Drinks Crackdown: New York reporters found THC beverages being sold in regular retail fridges without required ID checks, despite state rules capping THC at 1mg per serving while many cans appear far higher. Teen Mental Health Warning: A UK mother says an unregulated “weed pen” pushed her son into psychosis after two weeks of use, renewing calls for tighter controls on high-THC vapes. Impaired Driving Funding: California’s CHP awarded $41M from adult-use cannabis tax revenue to expand enforcement, training (including Drug Recognition Evaluators), and lab upgrades aimed at reducing drug-impaired driving. Local Cannabis Enforcement: Coventry police smashed a cannabis grow and disrupted a nearby setup “in the making,” urging residents to report suspicious activity. Medical Hemp Research/Policy: A study roundup highlights CBD/THC combinations showing promise for agitation in dementia, while regulators and clinicians continue pushing for better oversight of medical cannabis use. Industry & Markets: Tilray was reported beating a hemp protein claim suit “for now,” while hemp-related business news also includes funding and licensing updates across regions.

Impaired-Driving Enforcement: California CHP announced $41M+ in Proposition 64 grants for impaired-driving education, enforcement, and forensic toxicology testing—funded by cannabis tax revenue. Federal Hemp Deadline: THC drink makers face a Nov. 12, 2026 federal rule that could kick many hemp-derived cans out of the legal hemp category if they exceed 0.4 mg total THC per container, with industry pushing for a delay. Regulatory Watch (Hemp): Michigan’s Cannabis Regulatory Agency is holding a July 23 hearing on changes that could shape how lawful industrial hemp is received, processed, tested, labeled, and monitored. Medical/Clinical Claims in Court: Tilray won a temporary win in a suit over hemp product protein claims, while a separate CBD company seeks a $1.7M award tied to a late hemp-farm filing. Safety & Use Messaging: A Barrie drowning-prevention reminder explicitly warns that alcohol and cannabis can impair balance and judgment around water. Roadside Risk (Cannabis + Alcohol): RCMP reported alcohol and cannabis found in a Saskatchewan crash that killed Roughrider Jayden Dalke, with toxicology pending. Industry/Policy Signals: UFCW backs a federal bill to legalize cannabis, adding to momentum for broader federal reform.

M&A Watch: Vireo Growth will buy Cannabist cultivation, manufacturing and retail assets across Colorado, Illinois, Massachusetts, New Jersey and West Virginia for up to $35M (cash plus seller notes), with staged closings through 2026–27. Medical Cannabis Enforcement: New Zealand police charged a Christchurch medicinal cannabis licence holder after alleged licence breaches, including cannabis and paraphernalia found for personal use outside the authority. CBD Sleep Research: A small study tested CBD-coated pillow covers for shift workers; results were modest, with the biggest changes in self-reported sleep and anxiety rather than objective sleep measures. Regulation & Prescribing Standards: Australia’s ECS Botanics is pushing for stronger oversight and prescribing standards, citing price competition and regulatory scrutiny in the medicinal cannabis market. Public Safety / Cannabis-Linked Incident: A Scotland rescue reported a dog’s full recovery after suspected marijuana ingestion on Ben Nevis. Broader Policy Context: Maryland’s new social equity report says the state has programs but lacks statewide coordination and governance to make them work better.

Dementia Treatment Update: A Phase 2 trial (LiBBY) presented at the Alzheimer’s Association International Conference found a cannabis-based oral mix of THC 2mg + CBD 100mg twice daily improved agitation in late-stage dementia—about 84% improved by two weeks and nearly 90% by 12 weeks, versus far lower placebo results. Extraction Quality Watch: New peer-reviewed research (ACS Omega) says colder butane extraction can cut wax-derived hydrocarbons in cannabis concentrates while preserving cannabinoids and terpenes, and may shift what ends up in the inhaled aerosol. Policy & Access: A Penn State Q&A breaks down what marijuana rescheduling to Schedule III means in practice—medical value is recognized federally, but state rules still drive the real market. Industry & Regulation Pressure: Florida hemp businesses warn a planned federal ban on THC products (effective Nov. 12) could wipe out most current offerings under a “total THC” standard. Workplace & Safety: UFCW backs the Cannabis Administration and Opportunity Act, pushing for federal workplace protections and better job standards as legalization expands. Mental Health & Cannabis Use: A Journal of Affective Disorders study links cannabis use in young adults at bipolar risk to more trouble with daily responsibilities rather than simply higher use frequency.

Medical Cannabis in Pregnancy: UAMS researchers published a population-level look at how pregnant Arkansans use medical cannabis, analyzing 72,992 pregnancies (2019–2022) and finding 1.62% involved medical cannabis purchases; about two-thirds kept buying before and during pregnancy, while one-third started during pregnancy. Public Health Policy: New York City’s Mamdani administration made permanent a syringe redemption program that pays 20 cents per used syringe, keeping a $3M budget line and extending a contract with a nonprofit that runs eight drop sites. Forensics & Safety Tech: NIST expanded its mass-spectra “chemical fingerprints” library (Standard Reference Database 1A), updating its tool for identifying unknown substances across food, drugs, cosmetics, the environment, and more. Drug Enforcement & Courts: A UK case in Birmingham involved a cannabis-smoking mother who threatened a school with a bomb hoax; she avoided jail with a suspended sentence, while other court items this week continued to mix cannabis with broader criminal charges. CBD/Medical Market Access: Spain’s Curaleaf was reported as the first to supply medical cannabis under a new law, signaling continued expansion of regulated access.

Medical Cannabis Policy: Spain’s medicines regulator has approved Curaleaf’s standardized THC- and CBD-dominant cannabis preparations under the country’s new medical framework, with hospital-pharmacy availability “in due course,” signaling faster access for patients and a stronger European foothold for U.S. operators. Regulatory Reform (Personal Use): Jersey’s Health Minister says a withdrawn cannabis reform proposition will return “in due course,” after “a little bit of work” on options including possible shifts away from prosecution for small personal possession and a planned government-controlled production/sales trial for non-medical cannabis. Industry & Access: A Montana court report highlights ongoing enforcement around cannabis products, including a burglary case tied to stolen cannabis goods and scheduled sentencing. Criminal Justice & CBD/Cannabis Context: In North Carolina, a man sentenced for escaping a federal residential reentry center had tested positive for marijuana while there, underscoring how cannabis use can derail reentry compliance. Medical Hemp Angle: While not hemp-specific, the week’s recurring theme is tighter oversight of cannabis use and products alongside expanding regulated medical supply.

Medical cannabis policy & access: St. Kitts and Nevis has brought in former St. Vincent agriculture minister Saboto Caesar to revive a stalled medicinal cannabis industry after nearly four years with no licences issued, with a focus on banking/compliance and seed-to-sale tracking. Public health & safety: A new national campaign warns families that illegal drugs can be hidden in vapes marketed to young people, citing arrests and concerns about synthetic cannabinoids like Spice. Clinical research signal: An Epic Research study of 683,800 overdose patients found GLP-1 use was linked to lower repeat overdose risk, even after stopping the medication. Regulatory/industry operations: Oregon’s cannabis and alcohol licensing is moving fully digital via OLCC’s CAMP platform, while DEQ’s online permitting system was also recognized for modernization. Local cannabis market pressure: Humboldt County Growers Alliance leaders say the CA cannabis economy is stabilizing after years of decline, overproduction, and high compliance costs. Legal/consumer risk: A Missouri Supreme Court ruling in Monsanto v. Durnell turned on federal EPA risk determinations, shaping how warning-label disputes play out.

GLP-1 Safety Signal: An Epic Research study of 683,800 US overdose patients found GLP-1 receptor agonists were linked to a lower chance of repeat overdose—even after stopping the drug—adding to the conversation on safer long-term treatment. Cannabis Policy & Compliance Tech: Oregon’s cannabis and liquor regulators are going more digital, with the OLCC’s CAMP licensing platform and other online permitting tools earning state CIO recognition. Medical Cannabis Research: Multiple reports highlight new clinical interest in cannabinoids for hard-to-treat conditions, including agitation in late-stage dementia and other symptom-focused studies. Genetics in Hard Conditions: An international team identified a major genetic cause of primary hyperhidrosis tied to nerve overstimulation, pointing to more targeted treatments. DEA Rescheduling Fight: Coverage of the DEA rescheduling hearing says opposition witnesses undercut parts of the case, while briefs and next steps are set for later this month. Hemp Brand Launch: Hemp industry pioneer Jenna Zwagil’s Divine Earth Theory announced an upcoming line of hemp-derived wellness products. Roadside Drug Testing: New Zealand rolled out nationwide oral-fluid drug testing for THC and other drugs to curb drug-impaired driving. Local Cannabis Access Moves: Syracuse summer programs are training students for cannabis cultivation, compliance, and medical roles as the industry keeps professionalizing. Public Safety & Enforcement: Stories also covered drug-related arrests and prosecutions, including cases involving marijuana and other substances.

Medical Cannabis Evidence Check: A new JAMA review says medical cannabis may help some people with chronic noncancer pain, insomnia and anxiety, but the strongest support is limited by small studies and weak study design—while also flagging risks like cannabis use disorder and psychotic symptoms from high-potency products. CBD for Anxiety (India): Leiutis Pharma says India’s CDSCO approved Zenara Pharma’s synthetic cannabidiol oral solution (150 mg/mL) for mild-to-moderate anxiety disorders alongside CBT, with prescribing limited to psychiatrists and Phase III backing. Dementia Agitation Trial: A randomized, double-blind study presented at the Alzheimer’s Association conference found a THC/CBD combo (2 mg/100 mg twice daily) reduced agitation in late-stage dementia versus placebo, with benefits lasting through 12 weeks. Road Safety & Cannabis Impairment: Vermont is expanding training to spot cannabis-impaired drivers after crash data showed more cannabis-only incidents and fatalities; meanwhile Malaysia’s JPJ reported drug-positive commercial drivers often claimed they used substances to stay energized, including THC positives. Policy/Travel Warnings: Thailand tightened rules on cannabis in luggage, warning Americans could face up to 10 years in prison for cross-border transport without proper permissions. Regulated Market Moves (USVI): The Virgin Islands opened cannabis license applications with a Sept. 15 deadline, including cultivation, manufacturing, dispensary, and territory-wide micro-cultivation/research options.

Federal Rescheduling Process: A DEA judge has wrapped up the federal marijuana rescheduling hearing and set next steps, including post-hearing briefs due Aug. 17, as the agency prepares its recommendation. Medical Cannabis Access & Policy: Delaware’s marijuana commissioner says new state reforms add “clarity and structure,” including rules for terminally ill patients in healthcare facilities and THC-infused beverage regulation. Patient-Provider Communication: A new study finds communication gaps between cancer survivors and their providers around medical cannabis, highlighting differences in risk awareness and comfort discussing use. Clinical Research Roundup: Multiple studies point to potential symptom support—from cannabis-infused tea for happiness and sleep to oral cannabis spray for restless legs syndrome and THC/CBD combinations for agitation in dementia. Public Safety & Enforcement: Court and police reports continue to mix cannabis with broader drug enforcement, including a Scotland case where a Labrador was rescued after suspected cannabis ingestion and a Texas pursuit where authorities cited marijuana possession. State Legalization Politics: Arkansas gubernatorial candidates weigh recreational legalization, while Rhode Island attorney general race coverage continues to reference cannabis-related litigation and enforcement. CBD/Nutrition Angle: “Hemp hearts” coverage reiterates their non-intoxicating nutrition profile and protein/omega balance as U.S. availability grows.

Impaired Driving Training: Vermont is expanding training to help police spot cannabis-impaired drivers, citing rising crash involvement where only cannabis is detected. Public Health & Parenting: A new analysis finds mothers of Black newborns are far more likely to be referred to law enforcement over alleged pregnancy substance use, often tied to unreliable birth-time drug tests. Medical Cannabis Access & Care: A study and related reporting highlight ongoing gaps in finding doctors willing to prescribe medical cannabis, while another piece discusses research into THC/CBD combinations for agitation in late-stage dementia. Hemp Policy & Safety: A public screening in Australia spotlights “The Hemp Road Trip” and argues hemp legalization opened doors for farmers and wellness products. Product Claims Watch: Separate coverage flags concerns about “hemp hearts” and other hemp foods being marketed with broad health claims, underscoring the need for careful, evidence-based messaging. Local Governance: Honolulu’s community garden waitlists are stretching for years, showing how demand for food-growing space keeps outpacing supply. Workplace Drug Trends: New Zealand workplace testing shows cocaine positives up sharply, reinforcing how drug policy and workplace safety remain tightly linked.

Workplace Drug Trends: New Zealand’s latest Imperans workplace testing report shows cocaine positives up 68.5% year-over-year, while cannabis remains the biggest share of positives (64.4%), and opioids are down. Medical Records & Legal Cannabis: In Rochester, patients say a lab used by Rochester Regional Health is labeling marijuana results as “illicit drug” even when they come from legal dispensaries, prompting a public investigation and calls for clearer labeling. Hemp Industry Safety: After a June fire at a hemp processing facility in Prineville, Oregon, local fire officials are pushing for safety upgrades tied to the solvent-heavy processing step. Policy & Access: Fiji’s government says 75% of people consulted support exploring a medicinal cannabis industry, with a task force gathering input to set rules. Regulation Watch: A Massachusetts bill review targets synthetic kratom (7-OH) products, as regulators move toward tighter controls. Legal/Courts: A Zimbabwe magistrate questioned whether drug laws punish users more than politically connected suppliers, urging rehab-focused enforcement. Tech & Kids: A Common Sense Media report claims Google’s AI features “celebrate cannabis use” and fail harm-safety tests for children.